Anti-cancer Medicine
Erdafitinib 4 mg tablets (e.g., Erdanib, Balversa) are a kinase inhibitor used to treat adults with advanced or metastatic urothelial carcinoma (bladder cancer) possessing specific FGFR3 or FGFR2 genetic alterations. It is prescribed for patients whose cancer has progressed following platinum-containing chemotherapy